MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
AngioDynamics, Inc. (NASDAQ:ANGO)*
Organization & Developments: Angiodynamics
Parents
AngioDynamics, Inc. (NASDAQ:ANGO)*
Children
*Aging popualtion & diabetes are leading to a higher incidence of PAD
*Minimally invasive surgery equipment
*THERAPEUTIC/DIAGNOSTIC DEVICES THAT ENABLE TREAT of PERIPHERAL VASCULAR DISEASE
2006: Estimated that 12m people suffer from PAD (2006)
2013: Cash-Strapped AngioDynamics (ANGO) to Slash 80 To 100 Jobs In New York (2013)
2019: AngioDynamics buys Eximo to challenge Philips for PAD market, cutting EPS targets
2019: AngioDynamics Has Laser Focus on PAD with New Acquisition_Eximo Medical
2020: AngioDynamics: Cash Position Is Tight, It's Prove It Time In The Investment Debate
2022: AngioDynamics Now Finds Itself Deep In The Street's Doghouse_ seekingalpha.com
2022: AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold_ seekingalpha.com
2023: Execution Issues Continue To Undermine AngioDynamics Story (NASDAQ:ANGO)
2024: A Leaner AngioDynamics Is A High-Risk Execution-Driven Story
2024: AngioDynamics wins CE mark for atherectomy system
2024: AngioDynamics Xcela Port Catheter Problems Caused Sepsis Infection, Lawsuit Claims
2024: AngioDynamics, Inc. 2024 Q2 - Results - Earnings Call Presentation_ seekingalpha.com
2024: FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer
2025: AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares
Jumps
*Key People: Angiodynamics
Finance & Acquisitions: Angiodynamics